/HDRPF
HDRPF Stock - Epsilon Healthcare Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HDRPF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.63
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.60M | $6.65M | $7.11M | $5.50M | $7.36M |
| Gross Profit | $205,811 | $4.98M | $725,848 | $2.06M | $2.66M |
| Gross Margin | 3.7% | 74.9% | 10.2% | 37.4% | 36.2% |
| Operating Income | $-2,590,374 | $-2,415,886 | $-6,128,356 | $-7,051,311 | $-10,349,916 |
| Net Income | $-2,008,403 | $-1,090,990 | $-13,288,561 | $-8,908,397 | $-10,947,661 |
| Net Margin | -35.9% | -16.4% | -186.8% | -162.0% | -148.8% |
| EPS | $-0.01 | $-0.00 | $-0.06 | $-0.05 | $-0.07 |
Company Overview
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HDRPFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 14, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q2 2025 | May 16, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Nov 19, 2024 | — | — | — | — |
Q3 2024 | Sep 24, 2024 | — | — | — | — |
Q2 2024 | May 30, 2024 | — | — | — | — |
Q2 2024 | Apr 15, 2024 | — | — | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.02 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HDRPF
What is HDRPF's current stock price?
Epsilon Healthcare Limited (HDRPF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for HDRPF?
No analyst price targets are currently available for this stock.
What sector is Epsilon Healthcare Limited in?
Epsilon Healthcare Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is HDRPF's market cap?
Epsilon Healthcare Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does HDRPF pay dividends?
No, Epsilon Healthcare Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRDF
Acreage Holdings, Inc.
$0.12
Mkt Cap: $0.0B
ACRHF
Acreage Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CHNC
China Infrastructure Construction Corp.
$0.00
Mkt Cap: $0.0B
DLTNF
Delta 9 Cannabis Inc.
$0.01
Mkt Cap: $0.0B
GHSI
Guardion Health Sciences, Inc.
$3.25
Mkt Cap: $0.0B
HERTF
Heritage Cannabis Holdings Corp.
$0.00
Mkt Cap: $0.0B
IVITF
Invictus MD Strategies Corp.
$0.00
Mkt Cap: $0.0B
NDVAF
Indiva Limited
$0.02
Mkt Cap: $0.0B
PXMVF
Pixium Vision S.A.
$1.50
Mkt Cap: $0.0B
VVCIF
VIVO Cannabis Inc.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to HDRPF for comparison